Meeting
2018 Genitourinary Cancers Symposium
Phase I study of stereotactic body radiotherapy following radical prostatectomy.
Authors
Leslie Ballas
USC Keck School of Medicine Norris Comprehensive Cancer Center, Los Angeles, CA
Leslie Ballas , Monish Aron , Shamim Jhimlee , Igor Shuryak , Tanya B. Dorff , Dongyun Yang , David J. Brenner , Susan G. Groshen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT02446366
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr TPS158)
DOI
10.1200/JCO.2018.36.6_suppl.TPS158
Abstract #
TPS158
Poster Bd #
N21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
First Author: Timothy J Brown
Poster
2019 Genitourinary Cancers Symposium
Preoperative radiotherapy for high-risk prostate cancer (PORT-PC) trial.
First Author: Himanshu Nagar
Poster
2015 ASCO Annual Meeting
Phase I dose escalation trial using stereotactic body radiation therapy (SBRT) for partial breast irradiation (PBI).
First Author: Asal Shoushtari Rahimi
Poster
2024 ASCO Genitourinary Cancers Symposium
Stereotactic intensity modulated radiotherapy after radical prostatectomy (SCIMITAR): Two-year quality of life and toxicity outcomes of a multicenter phase II trial.
First Author: John Nikitas